规范放大和CDKN2A/B损失完善了IDH1/2-突变星细胞瘤的预后
Hia S Ghosh1, Ruchit V Patel2,1, Elizabeth B Claus3,1
1Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Neuro-oncology
|November 25, 2024
概括
像CDKN2A/B损失和基因放大等分子标记物有助于预测IDH突变天体细胞瘤的存活率. 将这些特征结合起来,将预后精细化,超越传统的分级,以便更好地分层患者.
科学领域:
- 神经瘤学神经瘤学
- 分子病理学分子病理学
- 基因组学就是基因组学.
背景情况:
- 组织学标准是结质瘤诊断的标准,但像CDKN2A/B这样的分子特征对IDH突变天体细胞瘤的同卵性损失影响存活率.
- 目前的分子标志物不能有效地区分组织学分级的IDH突变天体细胞瘤 (2和3级) 的生存结果.
研究的目的:
- 确定分层风险的分子特征,并完善IDH突变天体细胞瘤的预后预测.
- 研究CDKN2A/B状态和基因放大对整体存活时间的综合影响.
主要方法:
- 从公共和学术数据集 (1989-2020) 收集了998名成年IDH突变天体细胞瘤患者的队列.
- 采用多变量建模和公正的聚类来分析分子变化和分层患者风险.
- 根据瘤等级,CDKN2A/B损失 (同卵性/半卵性) 和焦点基因放大,评估整体存活率.
主要成果:
- 瘤等级,CDKN2A/B损失和/或焦点基因放大与降低整体存活率有关.
- 没有CDKN2A/B损失或焦点放大的2/3级IDH突变天体细胞瘤患者的存活时间最长 (205.7个月).
- 具有任何CDKN2A/B损失的IDH突变天体细胞瘤聚集在一起,无论等级如何,并显示出最差的生存结果.
结论:
- 将CDKN2A/B状态和基因放大与组织病理学等级的整合改善了IDH突变天体细胞瘤的生存预测.
- CDKN2A/B半双质损失和焦点基因放大的组合确定了一个具有中间预后的独特患者群体.
- 这些发现完善了IDH突变天体细胞瘤的分子分类,使得更精确的预后.
更多相关视频
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.4K
09:43Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
8.0K
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
